Discontinued — last reported Q3 '25

Other

Deferred compensation plan assets

West Pharmaceutical Services Deferred compensation plan assets decreased by 13.0% to $8.70M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 2.4%, from $8.50M to $8.70M. Over 5 years (FY 2020 to FY 2025), Deferred compensation plan assets shows a downward trend with a -4.8% CAGR.

Analysis

StatementBalance Sheet Statement
SectionOther
First reportedQ4 2021
Last reportedQ3 2025
Metric ID: other_deferred_compensation_plan_assets

Historical Data

20 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$14.60M$14.40M$15.50M$15.00M$12.90M$12.30M$12.50M$10.40M$11.10M$9.10M$10.20M$9.90M$10.40M$11.30M$11.10M$8.50M$9.50M$10.00M$10.00M$8.70M
QoQ Change—-1.4%+7.6%-3.2%-14.0%-4.7%+1.6%-16.8%+6.7%-18.0%+12.1%-2.9%+5.1%+8.7%-1.8%-23.4%+11.8%+5.3%+0.0%-13.0%
YoY Change————-11.6%-14.6%-19.4%-30.7%-14.0%-26.0%-18.4%-4.8%-6.3%+24.2%+8.8%-14.1%-8.7%-11.5%-9.9%+2.4%
Range$8.50M – $15.50M
CAGR-10.3%
Avg YoY Growth-9.7%
Median YoY Growth-11.6%

Frequently Asked Questions

What is West Pharmaceutical Services's deferred compensation plan assets?
West Pharmaceutical Services (WST) reported deferred compensation plan assets of $8.70M in Q1 2026.
How has West Pharmaceutical Services's deferred compensation plan assets changed year-over-year?
West Pharmaceutical Services's deferred compensation plan assets increased by 2.4% year-over-year, from $8.50M to $8.70M.
What is the long-term trend for West Pharmaceutical Services's deferred compensation plan assets?
Over 5 years (2020 to 2025), West Pharmaceutical Services's deferred compensation plan assets has grown at a -4.8% compound annual growth rate (CAGR), from $12.80M to $10.00M.